Compounds that can alter the endocrine system of animals have been detected in
water supplies around the world as the result of human activities. These
substances are known as endocrine-disrupting compounds (EDCs) and have been
linked to a variety of adverse effects in both humans and wildlife including hormone-dependent cancers, reproductive tract disorders, and reduction in
reproductive fitness. Pharmaceutical compounds and their metabolites have been
collectively termed pharmaceutically active compounds (PhACs). Many PhACs
have now been detected in surface water, a few of which have been detected in
finished drinking water. The detection of EDCs and PhACs in source water is of
great concern since these compounds have known physiological responses at low
concentrations. Personal care products (PCPs) create another class of emerging
contaminants that have been detected in surface and groundwater. Some PhACs
and PCPs (PPCPs) are highly persistent and can function as EDCs. The majority
of EDCs and PPCPs are more polar than traditional contaminants, such as
polychlorinated biphenyls, and several have acidic or basic moieties. These
properties, coupled with trace quantities, create unique challenges for both removal processes and analytical detection. There are three general approaches
for monitoring the removal of EDCs and PPCPs: direct measurement of target
compounds via analytical instrumentation; biological assays; and, indirect
chemical measurements of compounds classes (e.g., organic iodine). These
approaches are discussed in this paper with an emphasis on analytical methods for direct
measurements. As part of an AWWA Research Foundation project to assess the removal of EDCs
and PPCPs during water treatment, a method has been developed which uses
automated solid-phase extraction and both gas and liquid tandem mass
spectrometer detection. This method permits trace level identification and
quantitation of a broad group of EDC and PPCP compounds in various types of
water.
Includes 27 references, tables, figures.